# Cagrilintide vs Pramlintide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) Cagrilintide vs Pramlintide

Compared side by side

# Cagrilintide vs pramlintide: how they differ

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Both are copies of amylin, the fullness hormone the pancreas releases with insulin: pramlintide, the first amylin drug, lasts under an hour and is injected right before each main meal, while cagrilintide carries a fatty-acid chain that stretches its half-life to about a week. Pramlintide was FDA-approved in 2005, as Symlin, as an add-on to mealtime insulin in diabetes, and its US pens are being discontinued; cagrilintide isn’t approved on its own and is the amylin half of Novo Nordisk’s CagriSema. In obesity trials without insulin, pramlintide’s weight loss was about 6 to 7 kg beyond placebo at a year, and cagrilintide’s higher doses led to about 10–12% weight loss on their own.

## Side by side

| Compared | [Cagrilintide](https://pepvault.app/peptides/cagrilintide) | [Pramlintide](https://pepvault.app/peptides/pramlintide) |
| --- | --- | --- |
| Category | Metabolic & GLP-1 | Metabolic & GLP-1 |
| Also known as | Cagri, AM833, NNC0174-0833 | Symlin, SymlinPen, AC137 |
| What it is | A long-acting version of amylin, the fullness hormone the pancreas releases alongside insulin, given as a weekly shot. | The first amylin drug (Symlin), approved in 2005 for people with diabetes who use mealtime insulin: a shot before each main meal that slows digestion and makes people feel full sooner. |
| How it works | Long-acting, lipidated analogue of amylin, the satiety hormone the pancreas releases with insulin. It activates amylin receptors and the calcitonin receptor (a non-selective amylin agonist); amylin promotes fullness, slows stomach emptying and holds back glucagon after meals. A fatty-acid chain stretches its half-life to about a week, so it is a weekly shot, usually run beside a GLP-1. Not approved on its own: it is the amylin half of Novo Nordisk's CagriSema. | A synthetic copy of amylin, the hormone the pancreas releases with insulin after a meal, with three of its amino acids swapped for proline. It slows stomach emptying, blunts the after-meal rise in glucagon and acts in the brain to make people feel full, so they eat less. It lasts under an hour in the body, so it is injected right before each main meal. FDA-approved in 2005 as an add-on to mealtime insulin in type 1 and type 2 diabetes; it is the older, short-acting relative of cagrilintide, and its US pens are being discontinued. |
| Commonly reported | Feeling full sooner and portions shrinking, with nausea or constipation after step-ups and some injection-site reactions. It is not approved on its own. | Early fullness and nausea in the first weeks. It is the short-acting ancestor of weekly cagrilintide, and its US pens are being discontinued. |
| Studied range | Research range: 0.25–2.4 mg, starting dose 0.25 mg. Studied in research — not a recommendation. | FDA label: 15–120 mcg, starting dose 15 mcg. |
| How often | Weekly | 2–3x daily SubQ, right before major meals |
| Half-life | ~1 week (measured in people: 159–195 hours in a phase 1b trial) | ~0.8 hours (48 minutes, FDA label) |
| Route | SubQ injection | SubQ injection |
| Typical run | Trials run it continuously: 26 weeks in phase 2, 68 weeks in phase 3. Community use is mostly as a weekly add-on to a GLP-1. | FDA-approved for ongoing use with mealtime insulin; its placebo-controlled trials ran 26 to 52 weeks. If it is stopped (surgery, illness), the label restarts it with the same start-up steps. |
| Evidence | Established: clinical trials or FDA-approved use exists | Established: clinical trials or FDA-approved use exists |
| Common side effects | Nausea, constipation, diarrhea, injection-site reactions | Nausea, loss of appetite, vomiting, headache, fatigue, dizziness, low blood sugar (with insulin) |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide or pramlintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### Cagrilintide

- Day 1–28 · 0.25 mg The 0.25 mg start
- Day 29–364 · 0.5 mg 0.5 mg, the second step
- Day 57–364 · 1 mg 1 mg, the middle step
- Day 85–364 · 1.7 mg 1.7 mg, the step before 2.4 mg
- Day 113+ · 2.4 mg 2.4 mg, the phase 3 dose

[Every card for cagrilintide, with its sources](https://pepvault.app/peptides/cagrilintide#weeks)

### Pramlintide

- Day 1–14 · 15 mcg The 15 mcg start (type 1)
- Day 1–30 · 60 mcg 60 mcg, a start and a top dose
- Day 4–365 · 120 mcg 120 mcg, the type 2 dose
- Day 14–365 What it did for weight without insulin

[Every card for pramlintide, with its sources](https://pepvault.app/peptides/pramlintide#weeks)

## With this comparison

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### Pramlintide

- [Pramlintide: the full reference](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)

### Studies

- [CagriSema: 30.3% hit both BMI and waist-to-height targets at 68 weeks](https://pepvault.app/research/cagrilintide-redefine-1-2026)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 7 studies](https://pepvault.app/research#cagrilintide)
- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
- [All 8 studies](https://pepvault.app/research#pramlintide)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)

## Questions people ask

### How long do cagrilintide and pramlintide last?

The half-life of cagrilintide is ~1 week (measured in people: 159–195 hours in a phase 1b trial). The half-life of pramlintide is ~0.8 hours (48 minutes, FDA label).

### How often are cagrilintide and pramlintide taken?

Cagrilintide: weekly. Route: SubQ injection. Pramlintide: 2–3x daily SubQ, right before major meals. Route: SubQ injection.

### How are cagrilintide and pramlintide dosed in research?

The research range for cagrilintide is 0.25–2.4 mg, with a 0.25 mg starting dose. Studied in research — not a recommendation. The FDA label range for pramlintide is 15–120 mcg, with a 15 mcg starting dose.

### What are the common side effects of cagrilintide and pramlintide?

For cagrilintide, the library lists: nausea, constipation, diarrhea, injection-site reactions. For pramlintide: nausea, loss of appetite, vomiting, headache, fatigue, dizziness, low blood sugar (with insulin).

## Each one in full

- [Cagrilintide: dosage, half-life & reference guide](https://pepvault.app/peptides/cagrilintide)
- [Pramlintide: dosage, half-life & reference guide](https://pepvault.app/peptides/pramlintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cagrilintide or pramlintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide or pramlintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### Pramlintide

- [Pramlintide: the full reference](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)

### Studies

- [CagriSema: 30.3% hit both BMI and waist-to-height targets at 68 weeks](https://pepvault.app/research/cagrilintide-redefine-1-2026)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 7 studies](https://pepvault.app/research#cagrilintide)
- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
- [All 8 studies](https://pepvault.app/research#pramlintide)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)

<!--promo-->

PepVault for iPhone

## Taking cagrilintide or pramlintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Metabolic & GLP-1 peptides](https://pepvault.app/peptides#metabolic)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
